DAY 2 - Sunday, Nov. 11
RETINA SUBSPECIALTY DAY
Evidence suggests aspirin safety in AMD
Though the association of aspirin use and age-related macular degeneration (AMD) is controversial, the totality of evidence suggests there is no major harmful effect of aspirin use. » MORE
Anti-VEGF interpretation varies
Results from studies of anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration can be interpreted in a variety of ways, depending on the baseline bias of the individual. » MORE
CORNEA SUBSPECIALTY DAY
Glaucoma surgery enters cornea realm
Recently introduced microinvasive glaucoma surgery (MIGS) procedures are easy enough to be performed by cornea specialists, but the need for close surveillance of the glaucoma patient must be kept in mind. » MORE
Tests aid dry eye diagnosis
There are a variety of new diagnostic tests for dry eye and a number of reasons to incorporate these technologies into practice. » MORE
FROM THE SHOW FLOOR
Quantel laser earns FDA approval
Quantel Medical has received FDA 510(k) market clearance of its ophthalmic laser system (SupraScan 577 Laser) for treating a wide range of retinal diseases. » MORE
Zeiss debuts new OCT platforms
Carl Zeiss Meditec introduces new optical coherence tomography platforms that span the full spectrum of multi-modality imaging for glaucoma and retinal disease. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
